Ketek and shaky trial data

May 28, 2007

A look at how some of the shady data was obtained for this flawed antibiotic.



Related posts:

  1. Avandia and GSK: Trial data
  2. Door-to-antibiotics time for pneumonia
  3. P4P and claims data
  4. Interpreting data
  5. My take: ER naming rights, grading data, salary disparity
  6. Ketek is thisclose from being pulled
  7. Ketek: Next on the firing line


KevinMD.com on Facebook


  Follow on Twitter   Subscribe



Comments on this entry are closed.

Previous post: Dangers of herbal medicines

Next post: "The impacts of preventive medicine are often overstated"

Site Meter